KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

CareDx (CDNA) Other Accumulated Expenses (2016 - 2025)

CareDx's Other Accumulated Expenses history spans 8 years, with the latest figure at $20.2 million for Q3 2025.

On a quarterly basis, Other Accumulated Expenses changed N/A to $20.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $20.2 million, a N/A change, with the full-year FY2018 number at $2.0 million, up 428.53% from a year prior.
Other Accumulated Expenses hit $20.2 million in Q3 2025 for CareDx, roughly flat from $20.2 million in the prior quarter.
Over the last five years, Other Accumulated Expenses for CDNA hit a ceiling of $20.2 million in Q1 2025 and a floor of $20.2 million in Q1 2025.